0001375151-21-000020.txt : 20210317
0001375151-21-000020.hdr.sgml : 20210317
20210317160222
ACCESSION NUMBER: 0001375151-21-000020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210315
FILED AS OF DATE: 20210317
DATE AS OF CHANGE: 20210317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farfel Gail M
CENTRAL INDEX KEY: 0001614780
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 21750531
MAIL ADDRESS:
STREET 1: 142 TEMPLE STREET
STREET 2: SUITE 205
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 500
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 500
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
wf-form4_161601132751358.xml
FORM 4
X0306
4
2021-03-15
0
0001375151
ZOGENIX, INC.
ZGNX
0001614780
Farfel Gail M
C/O ZOGENIX, INC.
5959 HORTON STREET, SUITE 500
EMERYVILLE
CA
94608
0
1
0
0
EVP/Chief Development Officer
Common Stock
2021-03-15
4
M
0
1625
0
A
13109
D
Common Stock
2021-03-15
4
F
0
587
20.70
D
12522
D
Common Stock
2021-03-15
4
M
0
2031
0
A
14553
D
Common Stock
2021-03-15
4
F
0
735
20.70
D
13818
D
Common Stock
2021-03-15
4
M
0
1500
0
A
15318
D
Common Stock
2021-03-15
4
F
0
542
20.70
D
14776
D
Restricted Stock Units
2021-03-15
4
M
0
1625
0
D
Common Stock
1625.0
1625
D
Restricted Stock Units
2021-03-15
4
M
0
2031
0
D
Common Stock
2031.0
4062
D
Restricted Stock Units
2021-03-15
4
M
0
1500
0
D
Common Stock
1500.0
4500
D
Represents vesting of one-fourth (1/4) of restricted stock units granted on March 15, 2018.
Includes 305 shares acquired under the Company's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person.
Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 1.
Represents vesting of one-fourth (1/4) of restricted stock units granted on March 22, 2019.
Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 4.
Represents vesting of one-fourth (1/4) of restricted stock units granted on March 4, 2020.
Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 6.
Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock.
The restricted stock units vests in four equal installments on each of March 15, 2019, 2020, 2021 and 2022, subject to the reporting person's continuous service to the Company on such vesting date.
Not applicable.
The restricted stock units vest in four equal installments on each of March 15, 2020, 2021, 2022 and 2023, subject to the reporting person's continuous service to the Company on such vesting date.
The restricted stock units vests in four equal installments on each of March 15, 2021, 2022, 2023 and 2024, subject to the reporting person's continuous service to the Company on such vesting date.
/s/ Thomas Doyle, Attorney-in-fact for Gail Farfel
2021-03-17